Nano-emulsions: Overview and applications

Nanopharmaceutics: The Potential Application of Nanomaterials

Volumn , Issue , 2012, Pages 21-48

  Li, Xiang ^a   Anton, Nicolas ^a   Vandamme, Thierry ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

Administration; Characterization; Contrast media; High energy emulsification; Low energy emulsification; Nano emulsions; Nanocarriers; Nanotechnology

Indexed keywords

CHARACTERIZATION; CONTRAST MEDIA; DRUG DOSAGE; EMULSIFICATION; HYDROPHOBICITY; MANAGEMENT; MEDICAL NANOTECHNOLOGY; NANOTECHNOLOGY;

ACTIVE COMPOUNDS; CHARACTERIZATION METHODS; CONVENTIONAL APPROACH; HYDROPHOBIC DRUG; LOW ENERGY EMULSIFICATION; NANO-CARRIERS; NANO-EMULSIONS; SUBMICROMETERS;

EMULSIONS;

EID: 84973448956     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789814368674_0002     Document Type: Chapter

References (70)

1. Park K, Journal of Cot rolled Release, 120, 1 (2007).
2. Wang M, Thanou M, Pharmacological Research, 62, 90 (2010).
3. Ravichandran R, Nanobiotechnology, 5, 17 (2009).
4. Tosi G, Costantino L, Rivasi F, Ruozi B, Leo E, Vergoni A, Tacchi R, Bertolini A, Vandelli M, Forni F, Journal of Controlled Release, 122, 1 (2007).
5. Gutierrez J, Gonzalez C, Maestro A, Sole I, Pey C, Nolla J, Current Opinion in Colloid and Interface Science, 13, 245 (2008).
6. Anton N, Benoit J, Saulnier P, Journal of Controlled Release, 128, 185 (2008).
7. Solans C, Izquierdo P, Nolla JN, Azemar, Garcia-Celma M, Current Opinion in Colloid and Interface Science, 10, 102 (2005).
8. El-Aasser M, Sudol E, Journal of Coatings Technology Research, 1, 20 (2004).
9. Tadros T, Izquierdo P, Esquena J, Solans C, Advances in Colloid and Interface Science, 108, 303 (2004).
10. Sole I, Pey C, Maestro A, Gonzalez C, Porras M, Solans C, Gutierrez J, Journal of Colloid and Interface Science, 344, 417 (2010).
11. Huynh N, Passirani C, Saulnier P, Benoit J, International Journal of Pharmaceutics, 379, 201 (2009).
12. Shinoda K, Saito H, Journal of Colloid And Interface Science, 26, 70 (1968).
13. Caldero G, Garcia-Celma M, Solans C, Journal of Colloid and Interface Science, 353, 406 (2011).
14. Jafari S, Assadpoor E, He Y, Bhandari B, Food Hydrocolloids, 22, 1191 (2008).
15. Pinnamaneni S, Das N, Das S, Pharmazie, 58, 554 (2003).
16. Schultz S, Wagner G, Urban K, Ulrich J, Chemical Engineering and Technology, 27, 361 (2004).
17. M. Wulff-Perez, A.Torcello-Gomez, Galvez-Ruiz. M, Martm-Rodrfguez. A, Food Hydrocolloids, 23, 1096 (2009).
18. Seckkuarachchi I, Tanaka K, Kumazawa H, Industrial and Engineering Chemistry Research, 45, 372 (2006).
19. Rang M, Miller C, Journal of Colloid and Interface Science, 209, 179 (1999).
20. Izquierdo P, Esquena J, Tadros T, Dederen C, Garcia M, Azemar N, Solans C, Langmuir, 18, 26 (2002).
21. Izquierdo P, Esquena J, Tadros T, Dederen J, Feng J, Garcia-Celma M, Azemar N, Solans C, Langmuir, 20, 6594 (2004).
22. Anton N, Vandamme T, International Journal of Pharmaceutics, 377, 142 (2009).
23. Miller C, Colloids and Surfaces, 29, 89 (1988).
24. Anton N, Vandamme T, Nano-emulsions and Micro-emulsions: Clarifications of the Critical Differences (2010).
25. Merisko-Liversidge E, Liversidge G, Toxicologic Pathology, 36, 43 (2008).
26. Kelmann R, Kuminek G, Teixeira H, Koester L, International Journal of Pharmaceutics, 342, 231 (2007).
27. Date A, Nagarsenker M, International Journal of Pharmaceutics, 355, 19 (2008).
28. Constantinides P, Chaubal M, Shorr R, Advanced Drug Delivery Reviews, 60, 757 (2008).
29. Vandamme T, Progress in Retinal and Eye Research, 21, 15 (2002).
30. Ten Tije A, Verweij J, Loos W, Sparreboom A, Clinical Pharmacokinetics, 42, 665 (2003).
31. Constantinides P, Lambert K, Tustian A, Schneider B, Lalji S, Ma W, Wentzel B, Kessler D, Worah D, Quay S, Pharmaceutical Research, 17, 175 (2000).
32. Makidon P, Bielinska A, Nigavekar S, Janczak K, Knowlton J, Scott A, Mank N, Cao Z, Rathinavelu S, Beer M, Wilkinson J, Blanco L, Landers J, Jr. Baker, PLoS ONE, (2008).
33. de Vries A, Clusters E, Lub J, van den Bosch S, Nicolay K, Grull H, Biomaterials, 31, 6537 (2010).
34. Lim S, Lim J, Choi J, Hyung W, Kim H, Suh J, Kim K, Academic Radiology, 17, 985 (2010).
35. Strickley R, Pharmaceutical Research, 21, 201 (2004).
36. Zhang P, Liu Y, Feng N, Xu J, International Journal of Pharmaceutics, 355, 269 (2008).
37. Kohli K, Chopra S, Dhar D, Arora S, Khar R, Drug Discov Today, 15(21-22) 958 (2010)
38. Tiwari S, Amiji M, Journal of Nanoscience and Nanotechnology, 6, 3215 (2006).
39. Pouton C, European Journal of Pharmaceutical Sciences, 11, S93 (2000).
40. Cui J, Yu B, Zhao Y, Zhu W, Li H, Lou H, Zhai G, International Journal of Pharmaceutics, 371, 148 (2009).
41. Chen M, Advanced Drug Delivery Reviews, 60, 768 (2008).
42. Zvonar A, Berginc K, Kristl A, Gasperlin M, International Journal of Pharmaceutics, 388, 151 (2010).
43. Rao S, Agarwal P, Shao J, International Journal of Pharmaceutics, 362, 10 (2008).
44. Vyas T, Shahiwala A, Amiji M, International Journal of Pharmaceutics, 347, 93 (2008).
45. Belhaj N, Arab-Tehrany E, Linder M, Process Biochemistry, 45, 187 (2010).
46. Hatanaka J, Chikamori H, Sato H, Uchida S, Debari K, Onoue S, Yamada S, International Journal of Pharmaceutics, 396, 188 (2010).
47. Korting H, Schafer-Korting M, Carriers in the Topical Treatment of Skin Disease, 197, 435 (2010).
48. Cevc G, Vierl U, Journal of Controlled Release, 141, 277 (2010).
49. Heuschkel S, Goebel A, Neubert R, Journal of Pharmaceutical Sciences, 97, 603 (2008).
50. Baroli B, Ennas M, Loffredo F, Isola M, Pinna R, Lopez-Quintela M, Journal of Investigative Dermatology, 127, 1701 (2007).
51. Shakeel F, Baboota S, Ahuja A, Ali J, Shafiq S, Journal of Nanobiotechnology, 6, 8 (2008).
52. Shakeel F, Baboota S, Ahuja A, Ali J, Aqil M, Shafiq S, AAPS PharmSciTech, 8(4), 191 (2007).
53. Kim B, Won M, Lee K, Kim C, Drug Delivery, 15, 465 (2008).
54. Shakeel F, Baboota S, Ahuja A, Ali j, Shafiq S, Pharmazie, 63, 580 (2008).
55. Kumar D, Aqil M, Rizwan M, Sultana Y, Ali M, Pharmazie, 64, 80 (2009).
56. Haley B, Frenkel E, Urologic Oncology: Seminars and Original Investigations, 26, 570 (2008)
57. Brigger I, Dubernet C, Couvreur P, Advanced Drug Delivery Reviews, 54, 631 (2002).
58. Sunderland C, Sleiert M, Talmadge J, Derfus A, Barry S, Drug Development Research, 67, 70 (2006).
59. Singh R, Jr.Lillard J, Experimental and Molecular Pathology, 86, 215 (2009).
60. Rapoport N, Kennedy A, Shea J, Scaife C, Nam K, Journal of Controlled Release, 138, 268 (2009).
61. Constantinides P, Tustian A, Kessler D, Advanced Drug Delivery Reviews, 56, 1243 (2004).
62. Ganta S, Amiji M, Molecular Pharmaceutics, 6, 928 (2009).
63. Torchilin V, Advanced Drug Delivery Reviews, 54, 235 (2002).
64. Bogdanov Jr, Weissleder AR, Brady T, Advanced Drug Delivery Reviews, 16, 335 (1995).
65. Gunasekera U, Pankhurst Q, Douek M, Targeted Oncology, 4, 169 (2009).
66. Hahn M, Singh A, Sharma P, Brown S, Moudgil B, Analytical and Bioanalytical Chemistry, 399(1), 3 (2010).
67. Jarzyna P, Skajaa T, Gianella A, Cormode D, Samber D, Dickson S, Chen W, Griffioen A, Fayad Z, Mulder W, Biomaterials, 30, 6947 (2009).
68. Hallouard F, Anton N, Choquet P, Constantinesco A, Vandamme T, Biomaterials, 31, 6249 (2010).
69. Sanvicens N, Marco M, Trends in Biotechnology, 26, 425 (2008).
70. Cormode D, Skajaa T, Fayad Z, Mulder W, Arteriosclerosis, Thrombosis, and Vascular Biology, 29, 992 (2009).